Evidence map›Paper›PMID 38201256›Full record

ArticleCells2023

Jia Sheng Hu, Ruchi Malik, Vikaas S Sohal, John L Rubenstein, Daniel Vogt

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jia Sheng HuDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94158, USA.
Ruchi MalikDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94158, USA.
Vikaas S SohalDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94158, USA.
John L RubensteinDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94158, USA.
Daniel VogtDepartment of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503, USA.ORCID 0000-0003-1876-5936
University of California, San Francisco · USMichigan State University · US

Funding

Genetic Control of Basal Telencephalic DevelopmentR01MH081880 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JOHN L. R. · 2009 to 2023
$8.1M
Genetic Regulation of Telencephalon DevelopmentR37MH049428 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JOHN L. R. · 2008 to 2017
$5.9M
STRUCTURE, EXPRESSION &FUNCTION OF THE DLX GENE FAMILYR01MH049428 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUBENSTEIN, JOHN L. R. · 1992 to 2022
$5.8M
NIMH NIH HHS MH049428NIMH NIH HHS MH081880NIMH NIH HHS R01 MH049428NIMH NIH HHS R01 MH081880NIMH NIH HHS R37 MH049428
6 · The paper itself

Abstract

The mammalian target of rapamycin (mTOR) signaling pathway is a powerful regulator of cell proliferation, growth, synapse maintenance and cell fate. While intensely studied for its role in cancer, the role of mTOR signaling is just beginning to be uncovered in specific cell types that are implicated in neurodevelopmental disorders. Previously, loss of the

Indexed as

Neurodevelopmental DisordersVasoactive Intestinal PeptideApoptosisHumansInterneuronsTOR Serine-Threonine KinasesTOR Serine-Threonine KinasesVasoactive Intestinal PeptideapoptosisCGEcortical interneuronexcitabilityMTORTsc1VIP

Identifiers

PMID38201256
PMCPMC10777938
OpenAlexW4390232970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.